Home   ->   news   ->   Press Releases

Press Releases

WuXi PharmaTech Awarded in Deloitte Technology Fast 50 China 2009 List for the Fifth Consecutive Yea

November 30, 2009 – Shanghai, China – WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology, and medical-device research and development outsourcing company with operations in China and the United States, announced that it had been selected to the Deloitte Technology Fast 50 China 2009 list for the fifth consecutive year.  The list recognizes the 50 fast-growing companies in China's technology, media, and telecommunications industries based on revenue growth rates over the previous three years.  WuXi PharmaTech is one of only two companies to have won this award for five consecutive years.


"This recognition is a credit to the dedication and hard work of our employees and the high quality of service they deliver," said Dr. Ge Li, Chairman and Chief Executive Officer of WuXi PharmaTech.  "Through expansion of our capabilities and capacity, both in China and the United States, we are building a broad and fully integrated platform of pharmaceutical R&D services for our customers.  We are confident that our continued investment in this platform will generate strong future revenue growth."     

About WuXi AppTec and WuXi PharmaTech
WuXi PharmaTech is a leading pharmaceutical, biotechnology, and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, we provide a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. Our services are designed to help our global partners to improve the success of research and shorten the time of development cost effectively in discovering and developing drugs and medical devices. Please visit: http://www.wuxiapptec.com.

back to top